We are live on
!
Find out more
EPIME
Evelyn Partners Investment Management (Europe) Portfolio holdings
AUM
$291M
1-Year Est. Return
20.34%
This Fund
S&P 500
This Quarter
Est. Return
-3.16%
1 Year Est. Return
+20.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$291M
AUM Growth
-$17.7M
(-5.7%)
Cap. Flow
-$3.51M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
53.1%
Holding
190
New
5
Increased
13
Reduced
55
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$4.24M |
| 2 |
iShares MSCI World ETF
URTH
|
+$149K |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$132K |
| 4 |
Freeport-McMoran
FCX
|
+$81K |
| 5 |
Goldman Sachs
GS
|
+$74.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$744K |
| 2 |
UnitedHealth
UNH
|
+$663K |
| 3 |
Salesforce
CRM
|
+$631K |
| 4 |
First Trust Capital Strength ETF
FTCS
|
+$568K |
| 5 |
Mastercard
MA
|
+$414K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.54% |
| 2 | Technology | 8.6% |
| 3 | Materials | 8.56% |
| 4 | Communication Services | 5.89% |
| 5 | Healthcare | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Intuit
INTU
$89B
| $4.32K | ﹤0.01% |
10
| – | – |
|
177
Adobe
ADBE
$105B
| $3.65K | ﹤0.01% |
15
-65
| -81% | -$18K |
|
178
Occidental Petroleum
OXY
$55.9B
| $2.67K | ﹤0.01% |
41
| – | – |
|
179
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
| $2.37K | ﹤0.01% |
58
| – | – |
|
180
Nike
NKE
$61.9B
| $2.17K | ﹤0.01% |
41
| – | – |
|
181
PJT Partners
PJT
$4.38B
| $1.82K | ﹤0.01% |
13
| – | – |
|
|
DCH
182
Dauch Corp
DCH
$1.51B
| $783 | ﹤0.01% |
+132
| New | +$918 |
|
|
LND
183
BrasilAgro
LND
$359M
| $774 | ﹤0.01% |
183
| – | – |
|
184
Jackson Financial
JXN
$8.8B
| $740 | ﹤0.01% |
7
-44
| -86% | -$4.92K |
|
|
185
Occidental Petroleum Corp Warrants
OXY.WS
$32B
| $301 | ﹤0.01% |
7
| – | – |
|
186
Organon & Co
OGN
$3.57B
| $138 | ﹤0.01% |
23
| – | – |
|
187
Gran Tierra Energy
GTE
$317M
| $9 | ﹤0.01% |
1
| – | – |
|
188
Pfizer
PFE
$153B
| – | – |
-625
| Closed | -$15.6K |
|
189
Roper Technologies
ROP
$39.8B
| – | – |
-450
| Closed | -$200K |
|
190
Viatris
VTRS
$18.9B
| – | – |
-71
| Closed | -$884 |
|
Similar funds
ODFS
DP
OCM
FFA
SI
DIGDR
LFC
CCC
Evelyn Partners Investment Management (Europe)'s Q1 2026 Portfolio in Review
As of Q1 2026, Evelyn Partners Investment Management (Europe) held 190 positions worth $291M, down 5.7% from $308M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 4.2%. Evelyn Partners Investment Management (Europe) opened 5 new positions and exited 3, leaving the 190-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Materials.
- Evelyn Partners Investment Management (Europe)'s largest Q1 2026 buy was AstraZeneca: 21,991 shares worth $4.27M.
- Evelyn Partners Investment Management (Europe) added most to iShares MSCI World ETF in Q1 2026, an estimated $149K increase.
- Evelyn Partners Investment Management (Europe)'s biggest Q1 2026 reduction was CRH, cutting an estimated $744K.
- Evelyn Partners Investment Management (Europe) fully exited Roper Technologies in Q1 2026, selling an estimated $200K.
- Evelyn Partners Investment Management (Europe)'s ten largest holdings make up 53% of its $291M portfolio in Q1 2026.
- Evelyn Partners Investment Management (Europe) opened 5 new positions and closed 3 in Q1 2026.
- Evelyn Partners Investment Management (Europe)'s portfolio value fell 5.7% quarter-over-quarter to $291M.
Based on Evelyn Partners Investment Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.